A. Caton (no date) ‘The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons’, Development, 127(8), pp. 1751–1766. Available at: http://dev.biologists.org/content/127/8/1751.long.
A Cruz-Martínez (2004) ‘Single fiber electromyography (SFEMG) in mitochondrial diseases (MD)’, Electromyography and clinical neurophysiology [Preprint].
A. M. Gordon (2000) ‘Regulation of Contraction in Striated Muscle’, Physiological Reviews, 80(2), pp. 853–924. Available at: http://physrev.physiology.org/content/80/2/853.long.
Aartsma-Rus, A. (2012) ‘Overview on AON Design’, in A. Aartsma-Rus (ed.) Exon Skipping. Totowa, NJ: Humana Press, pp. 117–129. Available at: https://doi.org/10.1007/978-1-61779-767-5_8.
Addgene: CRISPR Guide (no date). Available at: https://www.addgene.org/crispr/guide/.
Ahmed, M. et al. (2016) ‘Targeting protein homeostasis in sporadic inclusion body myositis’, Science Translational Medicine, 8(331), pp. 331ra41-331ra41. Available at: https://doi.org/10.1126/scitranslmed.aad4583.
Al-Chalabi, A., van den Berg, L.H. and Veldink, J. (2016) ‘Gene discovery in amyotrophic lateral sclerosis: implications for clinical management’, Nature Reviews Neurology, 13(2), pp. 96–104. Available at: https://doi.org/10.1038/nrneurol.2016.182.
AM Rossor (2016) ‘Recent advances in the genetic neuropathies’, Current opinion in neurology, 29(5). Available at: https://doi.org/10.1097/WCO.0000000000000373.
Amato, A.A. and Greenberg, S.A. (2013) ‘Inflammatory Myopathies’, CONTINUUM: Lifelong Learning in Neurology, 19, pp. 1615–1633. Available at: https://doi.org/10.1212/01.CON.0000440662.26427.bd.
Amato, A.A. and Russell, J.A. (2008) Neuromuscular disorders. New York: McGraw-Hill.
‘American Journal of Respiratory and Critical Care Medicine’ (no date). Available at: http://www.atsjournals.org/doi/abs/10.1164/ajrccm.161.1.9901057.
‘American Journal of Roentgenology’ (no date). Available at: http://www.ajronline.org/doi/abs/10.2214/AJR.14.13755.
Andrew G. Engel (2015) ‘Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment’, The Lancet. Neurology, 14(4). Available at: https://doi.org/10.1016/S1474-4422(14)70201-7.
Antoine, J.-C. and Camdessanché, J.-P. (2013) ‘Paraneoplastic disorders of the peripheral nervous system’, La Presse Médicale, 42(6), pp. e235–e244. Available at: https://doi.org/10.1016/j.lpm.2013.01.059.
APCP (no date). Available at: http://apcp.csp.org.uk/.
Arthur-Farraj, P.J. et al. (2012) ‘c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration’, Neuron, 75(4), pp. 633–647. Available at: https://doi.org/10.1016/j.neuron.2012.06.021.
Auer-Grumbach, M. (2013) ‘Hereditary sensory and autonomic neuropathies’, in Peripheral Nerve Disorders. Elsevier, pp. 893–906. Available at: https://doi.org/10.1016/B978-0-444-52902-2.00050-3.
Balance and walking involvement in facioscapulohumeral dystrophy: a pilot study on the effects of custom lower limb orthoses - European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):169-78 - Minerva Medica - Journals (no date). Available at: https://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2013N02A0169.
Belaya, K. et al. (2015) ‘Mutations in cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies’, Brain, 138(9), pp. 2493–2504. Available at: https://doi.org/10.1093/brain/awv185.
Benson, M.K.D. (2011) Children’s neuromuscular disorders. London: Springer.
Berthelsen, M.P. et al. (2014) ‘Anti-gravity training improves walking capacity and postural balance in patients with muscular dystrophy’, Neuromuscular Disorders, 24(6), pp. 492–498. Available at: https://doi.org/10.1016/j.nmd.2014.03.001.
Beryl B. Cummings (2017) ‘Improving genetic diagnosis in Mendelian disease with transcriptome sequencing’, Science translational medicine, 9(386). Available at: https://doi.org/10.1126/scitranslmed.aal5209.
‘Best Practice in Memory Services: Learning from across England’ (no date). Available at: https://www.england.nhs.uk/wp-content/uploads/2014/12/memory-clinics-final.pdf.
Blottner, D. and Salanova, M. (2015) The neuromuscular system: from earth to space life science : neuromuscular cell signalling in disuse and exercise. Cham: Springer. Available at: http://UCL.eblib.com/patron/FullRecord.aspx?p=1967380.
Boers, M (Boers, M); Brooks, P (Brooks, P); Strand, CV (Strand, CV); Tugwell, P (Tugwell, P) (1998) ‘The OMERACT filter for outcome measures in rheumatology’, JOURNAL OF RHEUMATOLOGY JOURNAL OF RHEUMATOLOGY, 25(2), pp. 198–199. Available at: https://contentstore.cla.co.uk/secure/link?id=caecd7db-09ea-e611-80c9-005056af4099.
Boldrin, L. and Morgan, J.E. (2007) ‘Activating muscle stem cells: therapeutic potential in muscle diseases’, Current Opinion in Neurology, 20(5), pp. 577–582. Available at: https://doi.org/10.1097/WCO.0b013e3282ef5919.
Boldrin, L., Zammit, P.S. and Morgan, J.E. (2015) ‘Satellite cells from dystrophic muscle retain regenerative capacity’, Stem Cell Research, 14(1), pp. 20–29. Available at: https://doi.org/10.1016/j.scr.2014.10.007.
Bonanomi, D. and Pfaff, S.L. (2010) ‘Motor Axon Pathfinding’, Cold Spring Harbor Perspectives in Biology, 2(3), pp. a001735–a001735. Available at: https://doi.org/10.1101/cshperspect.a001735.
Bönnemann, C.G. et al. (2014) ‘Diagnostic approach to the congenital muscular dystrophies’, Neuromuscular Disorders, 24(4), pp. 289–311. Available at: https://doi.org/10.1016/j.nmd.2013.12.011.
Briggs, D. and Morgan, J.E. (2013) ‘Recent progress in satellite cell/myoblast engraftment - relevance for therapy’, FEBS Journal, 280(17), pp. 4281–4293. Available at: https://doi.org/10.1111/febs.12273.
Brosius Lutz, A. and Barres, B.A. (2014) ‘Contrasting the Glial Response to Axon Injury in the Central and Peripheral Nervous Systems’, Developmental Cell, 28(1), pp. 7–17. Available at: https://doi.org/10.1016/j.devcel.2013.12.002.
Bushby, K. et al. (2010a) ‘Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management’, The Lancet Neurology, 9(1), pp. 77–93. Available at: https://doi.org/10.1016/S1474-4422(09)70271-6.
Bushby, K. et al. (2010b) ‘Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care’, The Lancet Neurology, 9(2), pp. 177–189. Available at: https://doi.org/10.1016/S1474-4422(09)70272-8.
Bushby, K. et al. (2014) ‘Ataluren treatment of patients with nonsense mutation dystrophinopathy’, Muscle & Nerve, 50(4), pp. 477–487. Available at: https://doi.org/10.1002/mus.24332.
By:Hunter, S (Hunter, S); White, M (White, M); Thompson, M (Thompson, M) (1998) ‘Techniques to evaluate elderly human muscle function: A physiological basis’, JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 53(3). Available at: https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=6&SID=E3HXcKOaUmhvHimfaQi&page=1&doc=1.
Byung-Yong Park (2010) ‘Induction and Segregation of the Vertebrate Cranial Placodes’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK53175/.
C F George (1983) ‘Prescription information leaflets: a pilot study in general practice.’, British Medical Journal (Clinical research ed.), 287(6400). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1549423/.
Caballero-Hernandez, D. et al. (2016) ‘The “Omics” of Amyotrophic Lateral Sclerosis’, Trends in Molecular Medicine, 22(1), pp. 53–67. Available at: https://doi.org/10.1016/j.molmed.2015.11.001.
Cannon, S.C. (2011) ‘Channelopathies of Skeletal Muscle Excitability’, in R. Terjung (ed.) Comprehensive Physiology. Hoboken, NJ, USA: John Wiley & Sons, Inc., pp. 761–790. Available at: https://doi.org/10.1002/cphy.c140062.
Carr, A.S. et al. (2016) ‘A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK’, Journal of Neurology, Neurosurgery & Psychiatry, 87(6), pp. 620–627. Available at: https://doi.org/10.1136/jnnp-2015-310907.
Carrì, M.T., D’Ambrosi, N. and Cozzolino, M. (2017) ‘Pathways to mitochondrial dysfunction in ALS pathogenesis’, Biochemical and Biophysical Research Communications, 483(4), pp. 1187–1193. Available at: https://doi.org/10.1016/j.bbrc.2016.07.055.
Carstens, P.-O. and Schmidt, J. (2014) ‘Diagnosis, pathogenesis and treatment of myositis: recent advances’, Clinical & Experimental Immunology, 175(3), pp. 349–358. Available at: https://doi.org/10.1111/cei.12194.
Chhabra, A. (2014) ‘Peripheral MR Neurography’, Neuroimaging Clinics of North America, 24(1), pp. 79–89. Available at: https://doi.org/10.1016/j.nic.2013.03.033.
Cirak, S. et al. (2011) ‘Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study’, The Lancet, 378(9791), pp. 595–605. Available at: https://doi.org/10.1016/S0140-6736(11)60756-3.
Clarke, C. et al. (2009) Neurology: a Queen Square textbook. Chichester: Wiley-Blackwell. Available at: http://onlinelibrary.wiley.com/book/10.1002/9781444311709.
Clarke, C. et al. (eds) (2016) Neurology. Chichester, UK: John Wiley &;#38; Sons, Ltd. Available at: https://doi.org/10.1002/9781118486160.
Collins, M.P. et al. (2010) ‘Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary’, Journal of the Peripheral Nervous System, 15(3), pp. 176–184. Available at: https://doi.org/10.1111/j.1529-8027.2010.00281.x.
Collins, M.P. and Hadden, R.D. (2017) ‘The nonsystemic vasculitic neuropathies’, Nature Reviews Neurology, 13(5), pp. 302–316. Available at: https://doi.org/10.1038/nrneurol.2017.42.
Conover, J.C. et al. (1995) ‘Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4’, Nature, 375(6528), pp. 235–238. Available at: https://doi.org/10.1038/375235a0.
Conwit, R.A. et al. (2011) ‘Adding more muscle and nerve to clinical trials’, Muscle & Nerve, 44(5), pp. 695–702. Available at: https://doi.org/10.1002/mus.22130.
Couratier, P. et al. (2016) ‘Epidemiology of amyotrophic lateral sclerosis: A review of literature’, Revue Neurologique, 172(1), pp. 37–45. Available at: https://doi.org/10.1016/j.neurol.2015.11.002.
Craig, D.M. et al. (2015) ‘Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesis’, Frontiers in Physiology, 6. Available at: https://doi.org/10.3389/fphys.2015.00296.
Crisp, S.J., Kullmann, D.M. and Vincent, A. (2016a) ‘Autoimmune synaptopathies’, Nature Reviews Neuroscience, 17(2), pp. 103–117. Available at: https://doi.org/10.1038/nrn.2015.27.
Crisp, S.J., Kullmann, D.M. and Vincent, A. (2016b) ‘Autoimmune synaptopathies’, Nature Reviews Neuroscience, 17(2), pp. 103–117. Available at: https://doi.org/10.1038/nrn.2015.27.
Cruz, P.M.R., Palace, J. and Beeson, D. (2014) ‘Congenital myasthenic syndromes and the neuromuscular junction’, Current Opinion in Neurology, 27(5), pp. 566–575. Available at: https://doi.org/10.1097/WCO.0000000000000134.
Cup, E.H. et al. (2007) ‘Exercise Therapy and Other Types of Physical Therapy for Patients With Neuromuscular Diseases: A Systematic Review’, Archives of Physical Medicine and Rehabilitation, 88(11), pp. 1452–1464. Available at: https://doi.org/10.1016/j.apmr.2007.07.024.
Dalakas, M.C. (2015) ‘Inflammatory Muscle Diseases’, New England Journal of Medicine, 372(18), pp. 1734–1747. Available at: https://doi.org/10.1056/NEJMra1402225.
Darabid, H., Perez-Gonzalez, A.P. and Robitaille, R. (2014) ‘Neuromuscular synaptogenesis: coordinating partners with multiple functions’, Nature Reviews Neuroscience, 15(11), pp. 703–718. Available at: https://doi.org/10.1038/nrn3821.
Dasen, J.S. and Jessell, T.M. (2009) ‘Chapter Six Hox Networks and the Origins of Motor Neuron Diversity’, in Hox Genes. Elsevier, pp. 169–200. Available at: https://doi.org/10.1016/S0070-2153(09)88006-X.
Davidson, G.L. et al. (2012) ‘Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort’, Journal of Neurology, 259(8), pp. 1673–1685. Available at: https://doi.org/10.1007/s00415-011-6397-y.
Davies, A.M. (2013) ‘Regulation of Neuronal Survival by Neurotrophins in the Developing Peripheral Nervous System’, in Patterning and Cell Type Specification in the Developing CNS and PNS. Elsevier, pp. 303–311. Available at: https://doi.org/10.1016/B978-0-12-397265-1.00095-2.
Dimachkie, M.M. and Barohn, R.J. (2013) ‘Guillain-Barré Syndrome and Variants’, Neurologic Clinics, 31(2), pp. 491–510. Available at: https://doi.org/10.1016/j.ncl.2013.01.005.
Dubrey, S., Ackermann, E. and Gillmore, J. (2015) ‘The transthyretin amyloidoses: advances in therapy’, Postgraduate Medical Journal, 91(1078), pp. 439–448. Available at: https://doi.org/10.1136/postgradmedj-2014-133224.
Duncan, J.S. et al. (2016) ‘Brain imaging in the assessment for epilepsy surgery’, The Lancet Neurology, 15(4), pp. 420–433. Available at: https://doi.org/10.1016/S1474-4422(15)00383-X.
Ebens, A. et al. (1996) ‘Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons’, Neuron, 17(6), pp. 1157–1172. Available at: https://doi.org/10.1016/S0896-6273(00)80247-0.
Effects of axon diameter and myelination (video) | Khan Academy (no date). Available at: https://www.khanacademy.org/science/health-and-medicine/nervous-system-and-sensory-infor/neuron-membrane-potentials-2014-03-27T17:58:17.207Z/v/effects-of-axon-diameter-and-myelination.
Evers, M.M., Toonen, L.J.A. and van Roon-Mom, W.M.C. (2015) ‘Antisense oligonucleotides in therapy for neurodegenerative disorders’, Advanced Drug Delivery Reviews, 87, pp. 90–103. Available at: https://doi.org/10.1016/j.addr.2015.03.008.
Ferlini, A., Scotton, C. and Novelli, G. (2013) ‘Biomarkers in Rare Diseases’, Public Health Genomics, 16(6), pp. 313–321. Available at: https://doi.org/10.1159/000355938.
Fernández, A., Josa, S. and Montoliu, L. (2017) ‘A history of genome editing in mammals’, Mammalian Genome, 28(7–8), pp. 237–246. Available at: https://doi.org/10.1007/s00335-017-9699-2.
Forbes, S.C. et al. (2014) ‘Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study’, PLoS ONE, 9(9). Available at: https://doi.org/10.1371/journal.pone.0106435.
Free guides (no date). Available at: http://www.plainenglish.co.uk/free-guides.html.
Fuglsang-Frederiksen, A. (2006) ‘The role of different EMG methods in evaluating myopathy’, Clinical Neurophysiology, 117(6), pp. 1173–1189. Available at: https://doi.org/10.1016/j.clinph.2005.12.018.
Fuller, G. and Manford, M. (2010) Neurology: an illustrated colour text. 3rd ed. Edinburgh: Churchill Livingstone. Available at: https://www.dawsonera.com/guard/protected/dawson.jsp?name=https://shib-idp.ucl.ac.uk/shibboleth&dest=http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9780702048883.
Gabrielle Natalie Samuel (2017) ‘The UK’s 100,000 Genomes Project: manifesting policymakers’ expectations’, New Genetics and Society, 36(4). Available at: https://doi.org/10.1080/14636778.2017.1370671.
Garner, M., Ning, Z. and Francis, J. (2012) ‘A framework for the evaluation of patient information leaflets’, Health Expectations, 15(3), pp. 283–294. Available at: https://doi.org/10.1111/j.1369-7625.2011.00665.x.
Ghaoui, R. et al. (2015) ‘Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy’, JAMA Neurology, 72(12). Available at: https://doi.org/10.1001/jamaneurol.2015.2274.
Gilhus, N.E. (2016) ‘Myasthenia Gravis’, New England Journal of Medicine, 375(26), pp. 2570–2581. Available at: https://doi.org/10.1056/NEJMra1602678.
Glover, G.H. and Schneider, E. (1991) ‘Three-point dixon technique for true water/fat decomposition withB0 inhomogeneity correction’, Magnetic Resonance in Medicine, 18(2), pp. 371–383. Available at: https://doi.org/10.1002/mrm.1910180211.
Goemans, N.M. et al. (2011) ‘Systemic Administration of PRO051 in Duchenne’s Muscular Dystrophy’, New England Journal of Medicine, 364(16), pp. 1513–1522. Available at: https://doi.org/10.1056/NEJMoa1011367.
Gordon, E., Rohrer, J.D. and Fox, N.C. (2016) ‘Advances in neuroimaging in frontotemporal dementia’, Journal of Neurochemistry, 138, pp. 193–210. Available at: https://doi.org/10.1111/jnc.13656.
Gordon, T. and Sulaiman, O.A. (2012) ‘Nerve Regeneration in the Peripheral Nervous System’, in H. Kettenmann (ed.) Neuroglia. Oxford University Press, pp. 701–714. Available at: https://doi.org/10.1093/med/9780199794591.003.0055.
Great Britain. Audit Commission for Local Authorities and the National Health Service in England and Wales. (no date) What Seems to Be the Matter Communication (National Health Service Report) [Paperback]. Stationery Office.
Greenfield, A. (2017) ‘Editing mammalian genomes: ethical considerations’, Mammalian Genome, 28(7–8), pp. 388–393. Available at: https://doi.org/10.1007/s00335-017-9702-y.
Griffin, B.H., Chitty, L.S. and Bitner-Glindzicz, M. (2017) ‘The 100 000 Genomes Project: What it means for paediatrics’, Archives of disease in childhood - Education & practice edition, 102(2), pp. 105–107. Available at: https://doi.org/10.1136/archdischild-2016-311029.
Guidance for Paediatric Physiotherapists - Managing Neuromuscular Disorders (no date). Available at: http://apcp.csp.org.uk/publications/guidance-paediatric-physiotherapists-managing-neuromuscular-disorders.
Hardie, D.G. (2006) ‘AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle’, Physiology, 21(1), pp. 48–60. Available at: https://doi.org/10.1152/physiol.00044.2005.
Harland, R. (2000) ‘Neural induction’, Current Opinion in Genetics & Development, 10(4), pp. 357–362. Available at: https://doi.org/10.1016/S0959-437X(00)00096-4.
Harridge, S.D.R. et al. (1996) ‘Whole-muscle and single-fibre contractile properties and myosin heavy chain isoforms in humans’, Pflügers Archiv - European Journal of Physiology, 432(5), pp. 913–920. Available at: https://doi.org/10.1007/s004240050215.
Hawkins, P.N. et al. (2015) ‘Evolving landscape in the management of transthyretin amyloidosis’, Annals of Medicine, 47(8), pp. 625–638. Available at: https://doi.org/10.3109/07853890.2015.1068949.
Hawley, J.A. et al. (2014) ‘Integrative Biology of Exercise’, Cell, 159(4), pp. 738–749. Available at: https://doi.org/10.1016/j.cell.2014.10.029.
Hilton-Jones, D. and Turner, M.R. (eds) (2014) Oxford textbook of neuromuscular disorders. [Oxford]: Oxford University Press. Available at: http://dx.doi.org/10.1093/med/9780199698073.001.0001.
Hoch, W. et al. (2001) ‘Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies’, Nature Medicine, 7(3), pp. 365–368. Available at: https://doi.org/10.1038/85520.
Hoffmann, G.F., Zschocke, J. and Nyhan, W.L. (2009) Inherited metabolic diseases: a clinical approach. Heidelberg: Springer. Available at: http://dx.doi.org/10.1007/978-3-540-74723-9.
Hoier, B. and Hellsten, Y. (2014) ‘Exercise-Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF’, Microcirculation, 21(4), pp. 301–314. Available at: https://doi.org/10.1111/micc.12117.
Hollak, C.E.M. and Lachmann, R. (eds) (2016a) Inherited metabolic disease in adults: a clinical guide. [New York]: Oxford University Press. Available at: http://dx.doi.org/10.1093/med/9780199972135.001.0001.
Hollak, C.E.M. and Lachmann, R. (eds) (2016b) Inherited metabolic disease in adults: a clinical guide. [New York]: Oxford University Press. Available at: http://dx.doi.org/10.1093/med/9780199972135.001.0001.
Hollingsworth, K.G. et al. (2012) ‘Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: Consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France’, Neuromuscular Disorders, 22, pp. S54–S67. Available at: https://doi.org/10.1016/j.nmd.2012.06.005.
How to Write a Lay Summary | DCC How-to Guides (no date). Available at: http://www.dcc.ac.uk/resources/how-guides/.
How to Write a Lay Summary | Digital Curation Centre (no date). Available at: http://www.dcc.ac.uk/resources/how-guides/write-lay-summary.
Hull, J. et al. (2012) ‘British Thoracic Society guideline for respiratory management of children with neuromuscular weakness’, Thorax, 67(Suppl 1), pp. i1–i40. Available at: https://doi.org/10.1136/thoraxjnl-2012-201964.
Irene Colombo (2015) ‘Congenital myopathies: Natural history of a large pediatric cohort’, Neurology, 84(1). Available at: https://doi.org/10.1212/WNL.0000000000001110.
Irina Dudanova (2012) ‘Genetic Evidence for a Contribution of EphA:EphrinA Reverse Signaling to Motor Axon Guidance’, Journal of Neuroscience, 32(15), pp. 5209–5215. Available at: http://www.jneurosci.org/content/32/15/5209.
Jain, K.K. (ed.) (2015) Applied neurogenomics. New York, NY: Humana Press. Available at: http://dx.doi.org/10.1007/978-1-4939-2247-5.
Jean-Yves Hogrel (2016) ‘Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy’, Neurology, 86(11). Available at: https://doi.org/10.1212/WNL.0000000000002464.
Jeppesen, T.D. et al. (2006) ‘Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy’, Brain, 129(12), pp. 3402–3412. Available at: https://doi.org/10.1093/brain/awl149.
Jessell, T.M. (2000) ‘Neuronal specification in the spinal cord: inductive signals and transcriptional codes’, Nature Reviews Genetics, 1(1), pp. 20–29. Available at: https://doi.org/10.1038/35049541.
Jessen, K.R. and Mirsky, R. (2005) ‘The origin and development of glial cells in peripheral nerves’, Nature Reviews Neuroscience, 6(9), pp. 671–682. Available at: https://doi.org/10.1038/nrn1746.
Jessen, K.R. and Mirsky, R. (2016) ‘The repair Schwann cell and its function in regenerating nerves’, The Journal of Physiology, 594(13), pp. 3521–3531. Available at: https://doi.org/10.1113/JP270874.
Jessen, K.R., Mirsky, R. and Lloyd, A.C. (2015) ‘Schwann Cells: Development and Role in Nerve Repair’, Cold Spring Harbor Perspectives in Biology, 7(7). Available at: https://doi.org/10.1101/cshperspect.a020487.
Jones, D.A., Haan, A. de and Round, J.M. (2004) Skeletal muscle from molecules to movement: a textbook of muscle physiology for sport, exercise, physiotherapy and medicine. Edinburgh: Churchill Livingstone.
Kang, J.-H. et al. (2015) ‘The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans’, Alzheimer’s & Dementia, 11(7), pp. 772–791. Available at: https://doi.org/10.1016/j.jalz.2015.05.003.
Kanning, K.C., Kaplan, A. and Henderson, C.E. (2010) ‘Motor Neuron Diversity in Development and Disease’, Annual Review of Neuroscience, 33(1), pp. 409–440. Available at: https://doi.org/10.1146/annurev.neuro.051508.135722.
Kao, T.-J., Law, C. and Kania, A. (2012) ‘Eph and ephrin signaling: Lessons learned from spinal motor neurons’, Seminars in Cell & Developmental Biology, 23(1), pp. 83–91. Available at: https://doi.org/10.1016/j.semcdb.2011.10.016.
Karin E. Lundin (2015) ‘Oligonucleotide Therapies: The Past and the Present’, Human Gene Therapy, 26(8). Available at: https://doi.org/10.1089/hum.2015.070.
Keith Baar (2014) ‘Using Molecular Biology to Maximize Concurrent Training’, Sports Medicine (Auckland, N.z.), 44(Suppl 2). Available at: https://doi.org/10.1007/s40279-014-0252-0.
Kernell, D. (2006) The Motoneurone and its Muscle Fibres. Oxford University Press. Available at: https://doi.org/10.1093/acprof:oso/9780198526551.001.0001.
Khorkova, O. and Wahlestedt, C. (2017) ‘Oligonucleotide therapies for disorders of the nervous system’, Nature Biotechnology, 35(3), pp. 249–263. Available at: https://doi.org/10.1038/nbt.3784.
Kimberly Amburgey (2017) ‘A natural history study of X-linked myotubular myopathy’, Neurology, 89(13). Available at: https://doi.org/10.1212/WNL.0000000000004415.
Kinali, M. et al. (2009) ‘Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study’, The Lancet Neurology, 8(10), pp. 918–928. Available at: https://doi.org/10.1016/S1474-4422(09)70211-X.
Koneczny, I. et al. (2013) ‘MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters’, PLoS ONE, 8(11). Available at: https://doi.org/10.1371/journal.pone.0080695.
Koneczny, I., Cossins, J. and Vincent, A. (2014) ‘The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis’, Journal of Anatomy, 224(1), pp. 29–35. Available at: https://doi.org/10.1111/joa.12034.
Ladle, D.R., Pecho-Vrieseling, E. and Arber, S. (2007) ‘Assembly of Motor Circuits in the Spinal Cord: Driven to Function by Genetic and Experience-Dependent Mechanisms’, Neuron, 56(2), pp. 270–283. Available at: https://doi.org/10.1016/j.neuron.2007.09.026.
Leslie Jacobson (1999) ‘Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice’, Journal of Clinical Investigation, 103(7). Available at: https://doi.org/10.1172/JCI5943.
Li, L., Xiong, W.-C. and Mei, L. (2018) ‘Neuromuscular Junction Formation, Aging, and Disorders’, Annual Review of Physiology, 80(1). Available at: https://doi.org/10.1146/annurev-physiol-022516-034255.
Lin, G., Mao, D. and Bellen, H.J. (2017) ‘Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload’, in Fly Models of Human Diseases. Elsevier, pp. 111–171. Available at: https://doi.org/10.1016/bs.ctdb.2016.07.004.
Lu, C.-H. et al. (2015) ‘Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis’, Neurology, 84(22), pp. 2247–2257. Available at: https://doi.org/10.1212/WNL.0000000000001642.
Machado, P., Brady, S. and Hanna, M.G. (2013) ‘Update in inclusion body myositis’, Current Opinion in Rheumatology, 25(6), pp. 763–771. Available at: https://doi.org/10.1097/01.bor.0000434671.77891.9a.
Machado, P.M. et al. (2014) ‘Ongoing Developments in Sporadic Inclusion Body Myositis’, Current Rheumatology Reports, 16(12). Available at: https://doi.org/10.1007/s11926-014-0477-9.
Machado, P.M., Dimachkie, M.M. and Barohn, R.J. (2014) ‘Sporadic inclusion body myositis’, Current Opinion in Neurology, 27(5), pp. 591–598. Available at: https://doi.org/10.1097/WCO.0000000000000129.
Marie-Christine Birling (2017) ‘Modeling human disease in rodents by CRISPR/Cas9 genome editing’, Mammalian Genome, 28(7). Available at: https://doi.org/10.1007/s00335-017-9703-x.
Matthew N Meriggioli (2009) ‘Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity’, Lancet neurology, 8(5). Available at: https://doi.org/10.1016/S1474-4422(09)70063-8.
Matthews, E. et al. (2010) ‘The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment’, Brain, 133(1), pp. 9–22. Available at: https://doi.org/10.1093/brain/awp294.
Mendell, J.R. et al. (2013) ‘Eteplirsen for the treatment of Duchenne muscular dystrophy’, Annals of Neurology, 74(5), pp. 637–647. Available at: https://doi.org/10.1002/ana.23982.
Mendell, J.R. et al. (2016) ‘Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy’, Annals of Neurology, 79(2), pp. 257–271. Available at: https://doi.org/10.1002/ana.24555.
Menezes, M.P. and North, K.N. (2012) ‘Inherited neuromuscular disorders: Pathway to diagnosis’, Journal of Paediatrics and Child Health, 48(6), pp. 458–465. Available at: https://doi.org/10.1111/j.1440-1754.2011.02210.x.
Metzker, M.L. (2010) ‘Sequencing technologies — the next generation’, Nature Reviews Genetics, 11(1), pp. 31–46. Available at: https://doi.org/10.1038/nrg2626.
MGI-Mouse Genome Informatics -The international database resource for the laboratory mouse (no date). Available at: http://www.informatics.jax.org/.
Mhoriam Ahmed (2016) ‘Targeting Protein Homeostasis in Sporadic Inclusion Body Myositis’, Science translational medicine, 8(331). Available at: https://doi.org/10.1126/scitranslmed.aad4583.
Michael Benatar (2016) ‘ALS Biomarkers for Therapy Development: State of the Field & Future Directions’, Muscle & nerve, 53(2). Available at: https://doi.org/10.1002/mus.24979.
Michael P. Wiggs (2015) ‘Can endurance exercise preconditioning prevention disuse muscle atrophy?’, Frontiers in Physiology, 6. Available at: https://doi.org/10.3389/fphys.2015.00063.
Michell, A. (2013) Understanding EMG. Oxford University Press. Available at: https://doi.org/10.1093/med/9780199595501.001.0001.
Miguel A Martín (2014) ‘Glycogen Storage Disease Type V’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1344/.
Milestones timeline : Nature Milestones in DNA (no date). Available at: https://www.nature.com/milestones/miledna/timeline.html.
Monahan, Z., Shewmaker, F. and Pandey, U.B. (2016) ‘Stress granules at the intersection of autophagy and ALS’, Brain Research, 1649, pp. 189–200. Available at: https://doi.org/10.1016/j.brainres.2016.05.022.
Monk, K.R., Feltri, M.L. and Taveggia, C. (2015) ‘New insights on schwann cell development’, Glia, 63(8), pp. 1376–1393. Available at: https://doi.org/10.1002/glia.22852.
Morgan, S. and Orrell, R.W. (2016) ‘Pathogenesis of amyotrophic lateral sclerosis’, British Medical Bulletin, 119(1), pp. 87–98. Available at: https://doi.org/10.1093/bmb/ldw026.
Morrow, J.M. et al. (2016) ‘MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study’, The Lancet Neurology, 15(1), pp. 65–77. Available at: https://doi.org/10.1016/S1474-4422(15)00242-2.
‘Motor neurone disease: assessment and management | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/ng42.
Muntoni, F., Torelli, S. and Ferlini, A. (2003) ‘Dystrophin and mutations: one gene, several proteins, multiple phenotypes’, The Lancet Neurology, 2(12), pp. 731–740. Available at: https://doi.org/10.1016/S1474-4422(03)00585-4.
Muscular Dystrophy UK (no date). Available at: http://www.musculardystrophyuk.org/.
Nancy D Leslie (2014) ‘Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK6816/.
Nancy Leslie (2017) ‘Pompe Disease’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1261/.
Needham, M. and Mastaglia, F.L. (2016) ‘Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment’, Clinical Neurophysiology, 127(3), pp. 1764–1773. Available at: https://doi.org/10.1016/j.clinph.2015.12.011.
Nerve Signaling (no date). Available at: https://www.nobelprize.org/educational/medicine/nerve_signaling/index.html.
Neuromuscular | Department of Neurology (no date). Available at: https://neuro.wustl.edu/education/fellowships/neuromuscular/.
Neuromuscular Disease Centre (no date). Available at: http://neuromuscular.wustl.edu/.
Nishimune, H. et al. (2008) ‘Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction’, The Journal of Cell Biology, 182(6), pp. 1201–1215. Available at: https://doi.org/10.1083/jcb.200805095.
Nishimune, H. (2012) ‘Active zones of mammalian neuromuscular junctions: formation, density, and aging’, Annals of the New York Academy of Sciences, 1274(1), pp. 24–32. Available at: https://doi.org/10.1111/j.1749-6632.2012.06836.x.
North, K.N. et al. (2014a) ‘Approach to the diagnosis of congenital myopathies’, Neuromuscular Disorders, 24(2), pp. 97–116. Available at: https://doi.org/10.1016/j.nmd.2013.11.003.
North, K.N. et al. (2014b) ‘Approach to the diagnosis of congenital myopathies’, Neuromuscular Disorders, 24(2), pp. 97–116. Available at: https://doi.org/10.1016/j.nmd.2013.11.003.
Nowell, M. et al. (2017) ‘Resection planning in extratemporal epilepsy surgery using 3D multimodality imaging and intraoperative MRI’, British Journal of Neurosurgery, 31(4), pp. 468–470. Available at: https://doi.org/10.1080/02688697.2016.1265086.
O’Brien, T.D. et al. (2010) ‘In vivo measurements of muscle specific tension in adults and children’, Experimental Physiology, 95(1), pp. 202–210. Available at: https://doi.org/10.1113/expphysiol.2009.048967.
O’Connor, E. et al. (2018) ‘Clinical and research strategies for limb-girdle congenital myasthenic syndromes’, Annals of the New York Academy of Sciences [Preprint]. Available at: https://doi.org/10.1111/nyas.13520.
O’Grady, G.L. et al. (2016) ‘Diagnosis and etiology of congenital muscular dystrophy: We are halfway there’, Annals of Neurology, 80(1), pp. 101–111. Available at: https://doi.org/10.1002/ana.24687.
Olivé, M., Kley, R.A. and Goldfarb, L.G. (2013) ‘Myofibrillar myopathies’, Current Opinion in Neurology, 26(5), pp. 527–535. Available at: https://doi.org/10.1097/WCO.0b013e328364d6b1.
Olpin, S.E. et al. (2015) ‘The investigation and management of metabolic myopathies’, Journal of Clinical Pathology, 68(6), pp. 410–417. Available at: https://doi.org/10.1136/jclinpath-2014-202808.
OMIM - Online Mendelian Inheritance in Man (no date). Available at: https://www.omim.org/.
Ørngreen, M.C. and Vissing, J. (2017) ‘Treatment Opportunities in Patients With Metabolic Myopathies’, Current Treatment Options in Neurology, 19(11). Available at: https://doi.org/10.1007/s11940-017-0473-2.
Orrell, Richard WBarclay, Chris (no date) ‘Diagnosis and management of motor neurone disease’, Practitioner, 260, pp. 17–21. Available at: https://search.proquest.com/docview/1844334383?OpenUrlRefId=info:xri/sid:primo&accountid=14511.
Otto, M. et al. (2012) ‘Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS’, Amyotrophic Lateral Sclerosis, 13(1), pp. 1–10. Available at: https://doi.org/10.3109/17482968.2011.627589.
Paganoni, S. and Amato, A. (2013) ‘Electrodiagnostic Evaluation of Myopathies’, Physical Medicine and Rehabilitation Clinics of North America, 24(1), pp. 193–207. Available at: https://doi.org/10.1016/j.pmr.2012.08.017.
Part two - The specifics - Access to Understanding (no date). Available at: http://www.access2understanding.org/guidance/part-two-the-specifics/.
Pasterkamp, R.J. (2012) ‘Getting neural circuits into shape with semaphorins’, Nature Reviews Neuroscience, 13(9), pp. 605–618. Available at: https://doi.org/10.1038/nrn3302.
Peter S. Zammit (2004) ‘Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?’, The Journal of Cell Biology, 166(3). Available at: https://doi.org/10.1083/jcb.200312007.
Plante-Bordeneuve, V. et al. (2007) ‘Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)’, Neurology, 69(7), pp. 693–698. Available at: https://doi.org/10.1212/01.wnl.0000267338.45673.f4.
Preston, D.C. and Shapiro, B.E. (2013) Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations. 3rd ed. London: Elsevier Saunders.
Purves, D. (2001) Neuroscience. Bethesda: National Library of Medicine. Available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=neurosci.TOC&depth=2.
‘Qualification Process for Drug Development Tools’ (no date). Available at: https://www.fda.gov/downloads/drugs/guidances/ucm230597.pdf.
Quijano-Roy, S., Carlier, R.Y. and Fischer, D. (2011) ‘Muscle Imaging in Congenital Myopathies’, Seminars in Pediatric Neurology, 18(4), pp. 221–229. Available at: https://doi.org/10.1016/j.spen.2011.10.003.
R Bottinelli (1996) ‘Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence.’, The Journal of Physiology, 495(Pt 2). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1160815/.
R Klein (1994) ‘Role of neurotrophins in mouse neuronal development.’, The FASEB Journal, 8(10), pp. 738–744. Available at: http://www.fasebj.org/content/8/10/738.long.
Ravenscroft, G. et al. (2017) ‘New era in genetics of early-onset muscle disease: Breakthroughs and challenges’, Seminars in Cell & Developmental Biology, 64, pp. 160–170. Available at: https://doi.org/10.1016/j.semcdb.2016.08.002.
Ravenscroft, G., Laing, N.G. and Bönnemann, C.G. (2015) ‘Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus’, Brain, 138(2), pp. 246–268. Available at: https://doi.org/10.1093/brain/awu368.
Readable | Free Readability Test Tool (no date). Available at: https://www.webpagefx.com/tools/read-able/.
Rees, J.H. (2004) ‘Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage’, Journal of Neurology, Neurosurgery & Psychiatry, 75(suppl_2), pp. ii43–ii50. Available at: https://doi.org/10.1136/jnnp.2004.040378.
Reilly, M. and Fridman, V. (2015) ‘Inherited Neuropathies’, Seminars in Neurology, 35(04), pp. 407–423. Available at: https://doi.org/10.1055/s-0035-1558981.
Renton, A.E., Chiò, A. and Traynor, B.J. (2014) ‘State of play in amyotrophic lateral sclerosis genetics’, Nature Neuroscience, 17(1), pp. 17–23. Available at: https://doi.org/10.1038/nn.3584.
Richard J. Barohn (2014) ‘A PATTERN RECOGNITION APPROACH TO THE PATIENT WITH A SUSPECTED MYOPATHY’, Neurologic clinics, 32(3). Available at: https://doi.org/10.1016/j.ncl.2014.04.008.
Richards, S. et al. (2015) ‘Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology’, Genetics in Medicine, 17(5), pp. 405–423. Available at: https://doi.org/10.1038/gim.2015.30.
Ricotti, V. et al. (2013) ‘Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy’, Journal of Neurology, Neurosurgery & Psychiatry, 84(6), pp. 698–705. Available at: https://doi.org/10.1136/jnnp-2012-303902.
Robert M. Brownstone (2010) ‘Spinal interneurons providing input to the final common path during locomotion’, Progress in brain research, 187. Available at: https://doi.org/10.1016/B978-0-444-53613-6.00006-X.
Rodríguez Cruz, P.M. et al. (2014) ‘Congenital myopathies with secondary neuromuscular transmission defects; A case report and review of the literature’, Neuromuscular Disorders, 24(12), pp. 1103–1110. Available at: https://doi.org/10.1016/j.nmd.2014.07.005.
Rodríguez Cruz, P.M., Palace, J. and Beeson, D. (2014) ‘Inherited disorders of the neuromuscular junction: an update’, Journal of Neurology, 261(11), pp. 2234–2243. Available at: https://doi.org/10.1007/s00415-014-7520-7.
Ross, J. et al. (2012) ‘Defects in Glycosylation Impair Satellite Stem Cell Function and Niche Composition in the Muscles of the Dystrophic Large Mouse’, STEM CELLS, 30(10), pp. 2330–2341. Available at: https://doi.org/10.1002/stem.1197.
Rossor, A.M. et al. (2012) ‘The distal hereditary motor neuropathies’, Journal of Neurology, Neurosurgery & Psychiatry, 83(1), pp. 6–14. Available at: https://doi.org/10.1136/jnnp-2011-300952.
Rossor, A.M. et al. (2017) ‘Peripheral neuropathy in complex inherited diseases: an approach to diagnosis’, Journal of Neurology, Neurosurgery & Psychiatry, 88(10), pp. 846–863. Available at: https://doi.org/10.1136/jnnp-2016-313960.
Rossor, A.M., Evans, M.R.B. and Reilly, M.M. (2015a) ‘A practical approach to the genetic neuropathies’, Practical Neurology, 15(3), pp. 187–198. Available at: https://doi.org/10.1136/practneurol-2015-001095.
Rossor, A.M., Evans, M.R.B. and Reilly, M.M. (2015b) ‘A practical approach to the genetic neuropathies’, Practical Neurology, 15(3), pp. 187–198. Available at: https://doi.org/10.1136/practneurol-2015-001095.
Rossor, A.M., Evans, M.R.B. and Reilly, M.M. (2015c) ‘A practical approach to the genetic neuropathies’, Practical Neurology, 15(3), pp. 187–198. Available at: https://doi.org/10.1136/practneurol-2015-001095.
Rossor, A.M., Evans, M.R.B. and Reilly, M.M. (2015d) ‘A practical approach to the genetic neuropathies’, Practical Neurology, 15(3), pp. 187–198. Available at: https://doi.org/10.1136/practneurol-2015-001095.
Rossor, A.M., Evans, M.R.B. and Reilly, M.M. (2015e) ‘A practical approach to the genetic neuropathies’, Practical Neurology, 15(3), pp. 187–198. Available at: https://doi.org/10.1136/practneurol-2015-001095.
Rossor, A.M., Reilly, M.M. and Sleigh, J.N. (2018) ‘Antisense oligonucleotides and other genetic therapies made simple’, Practical Neurology [Preprint]. Available at: https://doi.org/10.1136/practneurol-2017-001764.
Rossor, A.M., Tomaselli, P.J. and Reilly, M.M. (2016a) ‘Recent advances in the genetic neuropathies’, Current Opinion in Neurology [Preprint]. Available at: https://doi.org/10.1097/WCO.0000000000000373.
Rossor, A.M., Tomaselli, P.J. and Reilly, M.M. (2016b) ‘Recent advances in the genetic neuropathies’, Current Opinion in Neurology [Preprint]. Available at: https://doi.org/10.1097/WCO.0000000000000373.
Rudolf, R. et al. (2014) ‘Degeneration of Neuromuscular Junction in Age and Dystrophy’, Frontiers in Aging Neuroscience, 6. Available at: https://doi.org/10.3389/fnagi.2014.00099.
Ruegsegger, C. and Saxena, S. (2016) ‘Proteostasis impairment in ALS’, Brain Research, 1648, pp. 571–579. Available at: https://doi.org/10.1016/j.brainres.2016.03.032.
‘Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial’ (2015) The Lancet Neurology, 14(9), pp. 883–892. Available at: https://doi.org/10.1016/S1474-4422(15)00152-0.
Salzer, J.L. (2015) ‘Schwann Cell Myelination’, Cold Spring Harbor Perspectives in Biology, 7(8). Available at: https://doi.org/10.1101/cshperspect.a020529.
Samuel, G.N. and Farsides, B. (2017) ‘Public trust and “ethics review” as a commodity: the case of Genomics England Limited and the UK’s 100,000 genomes project’, Medicine, Health Care and Philosophy [Preprint]. Available at: https://doi.org/10.1007/s11019-017-9810-1.
Saudubray, J.M., Baumgartner, M.R. and Walter, J. (eds) (2016) Inborn metabolic diseases: diagnosis and treatment. 6th edition. Berlin: Springer.
Schlosser, G. (2006) ‘Induction and specification of cranial placodes’, Developmental Biology, 294(2), pp. 303–351. Available at: https://doi.org/10.1016/j.ydbio.2006.03.009.
Schofield, D. et al. (2017) ‘Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases’, npj Genomic Medicine, 2(1). Available at: https://doi.org/10.1038/s41525-017-0006-7.
Schröder, R. and Schoser, B. (2009) ‘Myofibrillar Myopathies: A Clinical and Myopathological Guide’, Brain Pathology, 19(3), pp. 483–492. Available at: https://doi.org/10.1111/j.1750-3639.2009.00289.x.
Shaibani, A. (2014) A Video Atlas of Neuromuscular Disorders. Oxford University Press. Available at: https://doi.org/10.1093/med/9780199898152.001.0001.
Sharp, L. and Trivedi, J.R. (2014) ‘Treatment and Management of Neuromuscular Channelopathies’, Current Treatment Options in Neurology, 16(10). Available at: https://doi.org/10.1007/s11940-014-0313-6.
Simon, N.G. et al. (2014) ‘Quantifying disease progression in amyotrophic lateral sclerosis’, Annals of Neurology, 76(5), pp. 643–657. Available at: https://doi.org/10.1002/ana.24273.
Singhal, N. and Martin, P.T. (2011) ‘Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction’, Developmental Neurobiology, 71(11), pp. 982–1005. Available at: https://doi.org/10.1002/dneu.20953.
Spillane, J., Beeson, D.J. and Kullmann, D.M. (2010) ‘Myasthenia and related disorders of the neuromuscular junction’, Journal of Neurology, Neurosurgery & Psychiatry, 81(8), pp. 850–857. Available at: https://doi.org/10.1136/jnnp.2008.169367.
‘Strength training and aerobic exercise training for muscle disease - van der Kooi - 2005 - The Cochrane Library - Wiley Online Library’ (no date). Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003907.pub2/abstract?systemMessage=Wiley+Online+Library+usage+report+download+page+will+be+unavailable+on+Friday+24th+November+2017+at+21%3A00+EST+%2F+02.00+GMT+%2F+10%3A00+SGT+%28Saturday+25th+Nov+for+SGT+.
Sun, Y. et al. (2015) ‘Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?’, Human Mutation, 36(6), pp. 648–655. Available at: https://doi.org/10.1002/humu.22783.
Sveen, M.-L. et al. (2013) ‘Resistance training in patients with limb-girdle and becker muscular dystrophies’, Muscle & Nerve, 47(2), pp. 163–169. Available at: https://doi.org/10.1002/mus.23491.
T. D. Bunker (1983) ‘An information leaflet for surgical patients.’, Annals of The Royal College of Surgeons of England, 65(4). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494353/.
Tan, S.V. et al. (2011) ‘Refined exercise testing can aid dna-based diagnosis in muscle channelopathies’, Annals of Neurology, 69(2), pp. 328–340. Available at: https://doi.org/10.1002/ana.22238.
Taniguchi, M. et al. (1997) ‘Disruption of Semaphorin III/D Gene Causes Severe Abnormality in Peripheral Nerve Projection’, Neuron, 19(3), pp. 519–530. Available at: https://doi.org/10.1016/S0896-6273(00)80368-2.
Teboul, L. et al. (2017) ‘Introduction to Mammalian Genome Special Issue: Genome Editing’, Mammalian Genome, 28(7–8), pp. 235–236. Available at: https://doi.org/10.1007/s00335-017-9708-5.
Thiede-Stan, N.K. and Schwab, M.E. (2015) ‘Attractive and repulsive factors act through multi-subunit receptor complexes to regulate nerve fiber growth’, Journal of Cell Science, 128(14), pp. 2403–2414. Available at: https://doi.org/10.1242/jcs.165555.
Thomas Wieser (2017) ‘Carnitine Palmitoyltransferase II Deficiency’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1253/.
‘Toolkit for producing patient information.pdf’ (no date). Available at: https://www.uea.ac.uk/documents/246046/0/Toolkit+for+producing+patient+information.pdf.
Top tips for writing a lay summary | The Academy of Medical Sciences (no date). Available at: https://acmedsci.ac.uk/more/news/10-tips-for-writing-a-lay-summary.
Ulf Andreasson (2016) ‘Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders’, Alzheimer’s & Dementia : Diagnosis, Assessment & Disease Monitoring, 3. Available at: https://doi.org/10.1016/j.dadm.2016.05.005.
Vaithinathan, A.G. and Asokan, V. (2017) ‘Public health and precision medicine share a goal’, Journal of Evidence-Based Medicine, 10(2), pp. 76–80. Available at: https://doi.org/10.1111/jebm.12239.
Vakharia, V.N. et al. (2017) ‘Accuracy of intracranial electrode placement for stereoelectroencephalography: A systematic review and meta-analysis’, Epilepsia, 58(6), pp. 921–932. Available at: https://doi.org/10.1111/epi.13713.
Van Battum, E.Y., Brignani, S. and Pasterkamp, R.J. (2015) ‘Axon guidance proteins in neurological disorders’, The Lancet Neurology, 14(5), pp. 532–546. Available at: https://doi.org/10.1016/S1474-4422(14)70257-1.
Venance, S.L. et al. (2006) ‘The primary periodic paralyses: diagnosis, pathogenesis and treatment’, Brain, 129(1), pp. 8–17. Available at: https://doi.org/10.1093/brain/awh639.
Victorian Department of Health / University of Melbourne (no date). Available at: https://www2.health.vic.gov.au/.
Viegas, S. et al. (2012) ‘Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects’, Experimental Neurology, 234(2), pp. 506–512. Available at: https://doi.org/10.1016/j.expneurol.2012.01.025.
Vincent, A. (2002) ‘Timeline: Unravelling the pathogenesis of myasthenia gravis’, Nature Reviews Immunology, 2(10), pp. 797–804. Available at: https://doi.org/10.1038/nri916.
Wang, L. et al. (2011) ‘Anatomical Coupling of Sensory and Motor Nerve Trajectory via Axon Tracking’, Neuron, 71(2), pp. 263–277. Available at: https://doi.org/10.1016/j.neuron.2011.06.021.
Ward, S. (2005) ‘Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia’, Thorax, 60(12), pp. 1019–1024. Available at: https://doi.org/10.1136/thx.2004.037424.
Wattjes, M.P. and Fischer, D. (2013) Neuromuscular imaging. New York: Springer. Available at: https://www.dawsonera.com/abstract/9781461465522.
Wattjes, M.P., Kley, R.A. and Fischer, D. (2010) ‘Neuromuscular imaging in inherited muscle diseases’, European Radiology, 20(10), pp. 2447–2460. Available at: https://doi.org/10.1007/s00330-010-1799-2.
Welch, M.B. and Brummett, C.M. (2011) ‘Peripheral Nervous SystemAnatomy and Function’, in G.A. Mashour and R. Lydic (eds) Neuroscientific Foundations of Anesthesiology. Oxford University Press, pp. 133–140. Available at: https://doi.org/10.1093/med/9780195398243.003.0067.
Willcocks, R.J. et al. (2016) ‘Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort’, Annals of Neurology, 79(4), pp. 535–547. Available at: https://doi.org/10.1002/ana.24599.
Willison, H.J., Jacobs, B.C. and van Doorn, P.A. (2016) ‘Guillain-Barré syndrome’, The Lancet, 388(10045), pp. 717–727. Available at: https://doi.org/10.1016/S0140-6736(16)00339-1.
Wood, N. (2012) Neurogenetics. Cambridge: Cambridge University Press. Available at: https://doi.org/10.1017/CBO9781139087711.
Woollacott, I.O.C. and Rohrer, J.D. (2016) ‘The clinical spectrum of sporadic and familial forms of frontotemporal dementia’, Journal of Neurochemistry, 138, pp. 6–31. Available at: https://doi.org/10.1111/jnc.13654.
Yang, Y. et al. (2013) ‘Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders’, New England Journal of Medicine, 369(16), pp. 1502–1511. Available at: https://doi.org/10.1056/NEJMoa1306555.
Yates, M. et al. (2016) ‘EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis’, Annals of the Rheumatic Diseases, 75(9), pp. 1583–1594. Available at: https://doi.org/10.1136/annrheumdis-2016-209133.
